ZyVersa Therapeutics’ CEO, Stephen C. Glover, Featured on
WESTON, Fla., Jan. 10, 2024 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company ...
Read moreWESTON, Fla., Jan. 10, 2024 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company ...
Read moreMOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--inDrive, a global mobility and urban services platform, announces the appointment of Stephen Kruger as its Chief ...
Read moreSAN CARLOS, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Presto Automation (NASDAQ: PRST) announced it has appointed Steve Herbert as ...
Read moreNucleome Therapeutics appoints Dr Stephen Harrison as Chief Scientific Officer Key appointment bringing 30 years of drug discovery and development ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.